Sociedad Quimica y Minera de Chile SA (NYSE:SQM)’s share price traded up 5% during trading on Monday . The stock traded as high as $27.75 and last traded at $27.74, with a volume of 930,500 shares changing hands. The stock had previously closed at $26.43.

Several equities analysts recently commented on the stock. Bank of America Corp. reiterated a “hold” rating and set a $28.00 price target on shares of Sociedad Quimica y Minera de Chile SA in a report on Tuesday, July 5th. Zacks Investment Research upgraded shares of Sociedad Quimica y Minera de Chile SA from a “hold” rating to a “buy” rating and set a $27.00 price target on the stock in a report on Thursday, June 23rd. Scotiabank upgraded shares of Sociedad Quimica y Minera de Chile SA from a “sector perform” rating to an “outperform” rating in a report on Monday, June 6th. TheStreet upgraded shares of Sociedad Quimica y Minera de Chile SA from a “hold” rating to a “buy” rating in a report on Thursday, August 25th. Finally, Citigroup Inc. downgraded shares of Sociedad Quimica y Minera de Chile SA from a “neutral” rating to a “sell” rating in a report on Wednesday, July 13th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $22.20.

The company has a market capitalization of $7.30 billion and a P/E ratio of 35.25. The stock’s 50 day moving average is $25.07 and its 200-day moving average is $22.21.

Sociedad Quimica y Minera de Chile SA (SQM) is a producer of potassium nitrate and iodine chemicals. The Company operates in six segments: specialty plant nutrients, industrial chemicals, iodine and derivatives, lithium and derivatives, potassium, and other products and services. It produces four types of specialty plant nutrients: potassium nitrate, sodium nitrate, sodium potassium nitrate and specialty blends.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.